NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-099-2016-0-US-04 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US DIV 16/014,971 10206957 Abandoned PDF
NCI E-135-2018-0-US-01 METHOD AND APPARATUS FOR TESTING NEAR INFRARED-PHOTOIMMUNOTHERAPY TREATMENT US 62/688,031 Abandoned
NHLBI E-222-2022-3-US-01 Catheters and Manipulators with Deflectable Ends US 62/688,378 Expired
NICHD E-062-2015-0-CN-07 CODON-OPTIMIZED REDUCED-SIZE ATP7A CDNA AND USES FOR TREATMENT OF COPPER TRANSPORT DISORDERS CN National Stage 201680074686.6 Issued
NCI E-040-2012-0-JP-27 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen JP DIV 2018-117381 Issued
NCI E-085-2013-0-AU-11 Methods for Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood AU DIV 2018204458 Issued
NHGRI E-100-2017-0-PCT-02 CODON-OPTIMIZED HUMAN NPC1 GENES FOR THE TREATMENT OF NIEMANN-PICK TYPE C1 DEFICIENCY AND RELATED CONDITIONS PCT PCT PCT/US2018/038584 Expired
NCATS E-104-2017-0-PCT-02 INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE AND HISTONE DEACETYLASE FOR TREATMENT OF CANCER PCT PCT PCT/US2018/038507 Expired
NCATS E-104-2017-0-US-03 INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE AND HISTONE DEACETYLASE FOR TREATMENT OF CANCER US National Stage 16/621,290 Abandoned
NHGRI E-100-2017-0-EP-04 CODON-OPTIMIZED HUMAN NPC1 GENES FOR THE TREATMENT OF NIEMANN-PICK TYPE C1 DEFICIENCY AND RELATED CONDITIONS EP National Stage 18740403.3 Abandoned
NCATS E-050-2012-0-JP-13 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases JP DIV 2018-116666 Abandoned
NHGRI E-100-2017-0-CA-03 CODON-OPTIMIZED HUMAN NPC1 GENES FOR THE TREATMENT OF NIEMANN-PICK TYPE C1 DEFICIENCY AND RELATED CONDITIONS CA National Stage 3068010 Pending
NLM E-107-2010-2-US-21 DETECTION OF 5-HYDROXYMETHYLCYTOSINE BY GLYCOSYLATION US CON 16/012,510 10508301 Issued PDF
NLM E-107-2010-2-US-20 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/012,280 10337053 Issued PDF
NLM E-110-2016-2-AU-02 Novel CRISPR Enzymes And Systems AU National Stage 2016279062 Abandoned
NLM E-111-2016-7-AU-02 Novel CRISPR Enzymes And Systems AU National Stage 2016279077 Abandoned
NIA E-051-2008-0-US-02 PLASMA CELL CYTOKINE VEHICLE CONTAINING FUSION PROTEINS FOR TARGETED INTRODUCTION OF SIRNA INTO CELLS AND TISSUES US CIP 16/011,263 10485879 Abandoned PDF
NCI E-234-2014-1-US-14 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF US CON 16/011,292 Abandoned
NICHD E-026-2019-0-US-01 Myomerger As A Membrane Disruptor US 62/685,320 Abandoned
NCI E-282-2016-2-HK-34 Methods For Pre-conditioning Patients For Cell Therapy HK CN 18107815.8 Abandoned
NCI E-291-2012-0-AU-16 M971 Chimeric Antigen Receptors AU DIV 2018204257 Issued
NCI E-062-2018-0-US-01 Compound and METHODS OF TREATING HBV US 62/685,145 Abandoned
NCI E-060-2018-0-US-01 CANCER TREATMENT METHODS US 62/685,026 Abandoned
NCI E-010-2016-2-KR-08 Anti-BCMA Polypeptides and Proteins KR National Stage 10-2018-7016668 Issued
NCI E-264-2011-0-JP-08 Delivery Of Packaged RNA To Mammalian Cells JP DIV 2018-111489 Issued
NCI E-184-2018-2-PCT-01 Methods For Diagnosing Breast Cancer PCT PCT COMB PCT/HU2018/050029 Expired
NHGRI E-275-2015-0-US-04 GENE THERAPY FOR COMBINED METHYLMALONIC ACIDEMIA/ACIDURIA AND HYPERHOMOCYSTEINEMIA/HOMOCYSTINURIA, COBALAMIN C TYPE, AND DEFICIENCY OF MMACHC US National Stage 16/061,091 11510998 Issued PDF
NHLBI E-201-2016-0-JP-05 Annuloplasty Procedures, Related Devices And Methods JP National Stage 2019-510584 Issued
NIAID E-037-2016-0-US-10 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS US National Stage 16/061,316 10953083 Issued PDF
CC E-109-2017-0-PCT-02 PROGRESSIVE AND MULTI-PATH HOLISTICALLY NESTED NETWORKS FOR SEGMENTATION PCT PCT PCT/US2018/036682 Expired
NIAID E-124-2018-0-US-01 NEW COMPOSITIONS AND DETECTION METHODS FOR ONCHOCERCA VOLVULUS INFECTION US 62/682,678 Abandoned
NIBIB E-005-2012-3-JP-10 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS JP National Stage 2019-548055 Issued
NIBIB E-005-2012-3-PCT-07 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS PCT PCT PCT/US2018/036265 Expired
NIBIB E-158-2015-0-US-03 VESICLE CONTAINING METALLIC NANOPARTICLE AND METHOD FOR PRODUCTION THEREOF US National Stage 15/781,940 Abandoned
NINDS E-101-2012-1-US-24 Deuterated 3,4-Dihydroxyphenylserine (Deuterated L-DOPS) US CON 16/000,965 Abandoned
NCI E-172-2017-1-PCT-01 METHOD FOR DETERMINING LYMPHOMA TYPE PCT PCT PCT/US2018/036084 Expired
NCI E-107-2017-0-PCT-02 T-CELLS MODIFIED TO OVEREXPRESS PHF19 PCT PCT PCT/US2018/036125 Expired
NCI E-266-2011-0-EP-11 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage EP DIV 18175738.6 Issued
NCI E-266-2011-0-GB-45 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage GB EP 18175738.6 Issued
NCI E-266-2011-0-IT-48 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage IT EP 18175738.6 Issued
NCI E-266-2011-0-SI-53 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage SI EP 18175738.6 Issued
NCI E-266-2011-0-SK-54 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage SK EP 18175738.6 Issued
NCI E-266-2011-0-PL-50 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage PL EP 18175738.6 Issued
NCI E-266-2011-0-NL-49 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage NL EP 18175738.6 Issued
NCI E-266-2011-0-NO-56 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage NO EP 18175738.6 Issued
NCI E-266-2011-0-PT-51 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage PT EP 18175738.6 Issued
NCI E-266-2011-0-AT-38 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage AT EP 18175738.6 Issued
NCI E-266-2011-0-BE-39 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage BE EP 18175738.6 Issued
NCI E-266-2011-0-IE-47 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage IE EP 18175738.6 Issued
NCI E-266-2011-0-GR-46 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage GR EP 18175738.6 Issued